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Coccidioides immitis and C. posadasii. As the incidence of 
symptomatic Coccidioidomycosis increases worldwide, vaccine development strategy against Coccidioides is needed for both immunocompetent 
and immunocompromized individuals. An insight about PRA antigens in the pathogenesis of Coccidioidomycosis has the potential to develop a 
therapeutic intervention. 
Methods: In this study of ANN, SMM and QM based servers were used to predict promiscuous epitopes. Epitope structures were modeled using De 
novo based PEPFOLD server and minimized using Swiss model server. Further the modeled epitopes were tested for their binding affinity towards 
HLA alleles by means of peptide protein docking studies involving autodock. 
Results: A total of six antigenic epitopes ARISVSNIV, GRPTASTPA, ALNLFVEAL, LVAAGLASA, FSHALJALV, AEPTHEPTE of PRA showed hydrogen 
bonding with HLA alleles HLA-A*02:03, HLA B*27:05, HLA-A*02:01 with considerable bond distance. Thus, this systematic study on epitopes of 
      Keywords: HLA-A*02:03, HLA-B*27:05, HLA-A*02:01, PRA antigen, Epitope, Coccidioidomycosis, Vaccine 
Coccidioides study would be helpful in designing and developing novel PRA antigen based vaccine and inhibitor. 
Conclusion: These predicted sequences are potential vaccine candidates but functional/biological assays should be performed to verify whether 
they are indeed appropriate to be included in a vaccine formulation. 
 
INTRODUCTION 
Coccidioides immitis and C. posadasii are the two nearly identical 
species of pathogenic fungal species are the prominent cause for 
Coccidioidomycosis (also known as Valley Fever), they grow in the 
top 2-8 inches of soil in semi-arid regions and produces 
arthroconidia, highly infectious propagules that can be disrupted 
from the ground and inhaled, where they can produce acute 
pulmonary infection in humans and many mammals [1-3]. 
Coccidioidomycosis infection will remain asymptomatic or present 
with mild respiratory symptoms among sixty percentages of 
infected people[4]. Approximately 40% of infections result in 
symptomatic disease, typically arising one to four weeks after 
exposure, which can resemble ordinary influenza, with fever, cough, 
fatigue, dyspnea, headache, myalgia and arthralgia.  
The disease is considered non-transmissible, although rare instances 
of transmission have occurred, including via organ transplantation 
[5] and inhalation of spores growing in visecro-cutaneous fistulae. A 
low percentage of symptomatic infections progress, resulting in 
extrathoracic dissemination,with hematogenous spread to the 
central nervous system, skin, joints, major organs or bones and 
result in chronic (months to years) and even fatal disease [6,7]. 
Persons at increased risk of disseminated coccidioidomycosis 
include immune compromised persons, e. g., HIV/AIDS, diabetics, 
pregnant women [8,9] and persons of certain race/ethnicities, 
particularly Blacks Filipinos and Asians [10].  
The Ag2/PRA- proline-rich coccidioidal antigen is a protein 
composed of 194-amino-acid residues which is a component of a 
glycopeptide. Several studies reveal, either protein vaccines using 
recombinant Ag2/PRA (rAg2/PRA) or DNA vaccines based on the 
sequence encoding Ag2/PRA would aid protection from lethal 
coccidioidal infection in mice [11,12, 13,14].  
Despite numerous investigations, there is no real drug available for 
the treatment of the Coccidioidomycosis. In the absence of effective 
antiviral treatment, prevention through vaccination would greatly 
reduce morbidity and mortality associated with coccidiomycosis 
infections. Epitope mapping is the process of identifying the binding 
sites, or epitopes, of antibodies on their target antigens. Epitope 
mapping has become one of the key elements of both vaccine and 
drug development. Predicting immune epitope for T cell epitopes 
using computational methods assisting in assessing the infectious 
organism for imuunogenic antigens. An immune response elucidated 
by peptide based vaccines which in turn present immunogenic 
peptides to major histo compatability complex [15]. It is well 
established that T cells play a critical role in inducing immune 
response against foreign antigen. But for their activation, the 
antigenic fragment must bind to MHC molecules. There by predicting 
which antigenic fragment can bind to the MHC molecule is the first 
bottlenecks in vaccine design. As there is no experimentally resolved 
structure of PRA protein, it is challenging to select proper target that 
would lead to predict epitope and ligand binding sites in protein.  
Hence, this study aims to investigate the PRA gene with special focus 
on the structural and functional aspects through bioinformatics 
approach. Studies on HLA allelic diversity of among Asians 
population revealed some common alleles such as HLA-A*02:01. 
HLA-A*02:03[16],HLA-B*27:05[17]. We aimed to find out the 
epitope interaction with HLA-A*02:01, HLA-A*02:03, HLA-B*27:05 
using the insilico tools and the protein-protein docking studies, a 
critical step in the development of vaccines candidates.  
MATERIALS AND METHODS 
Protein Sequence retrieval 
The sequence of the complete CDS protein of Coccidioides immitis 
retrieved from Enterz protein database from NCBI (http://www. 
ncbi. nlm. nih. gov) has 194 amino acid residues. The sequence was 
saved in FASTA format and used for further analysis.  
Potential epitope prediction of antigenic protein 
To predict the T cell epitopes in PRA antigenic region of Coccidioides a 
systematic approach was adapted based on different algorithms. PRA 
antigen for the alleles HLA-A*02:03, HLA B*27:05, HLA-A*02:01 were 
predicted by using different Insilco tools like HLAPred(http://www. 
imtech. res. in/raghava/hlapred/), MHCPred[18], MAPPP[19], 
IEDB(www. iedb. org) [20] which are based on ANN (Artificial Neural 
Network), SMM (Stabilized Matrix Alignment Method) algorithm and 
“Quantitative Matrices” and “Additive Method” method. 
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De novo modeling of the epitopes 
All the predicted epitopes were obtained in the form of small 
peptide sequences (nanomers). The three dimensional structures of 
small peptides (epitopes) were required to find out their prominent 
interaction with HLA alleles, so we constructed the three 
dimensional model for all predicted promiscuous epitopes using de 
novo based prediction server PEP-FOLD[21] that modeled linear 
peptides structure up to 36 amino acids with an averaged RMSD of 
2.1 A from NMR structure, with user specified constraints such as 
disulfide bonds and inter-residue proximities. Further energy 
minimization was done for these nanomeric peptides using Swiss 
PDB viewer[22] (http://swissmodel. expasy. org). 
HLA allele sequence retrieval and Homology modeling and 
structure refinement of 
The HLA-A*02:03, HLA-B*27:05. HLA-A*02:01 alleles sequences 
were retrieved from IMGT/HLA (
HLA allele 
http://www. ebi. ac. uk) database, 
and three dimensional structure of 1HHG (HLA-B*27:05) was 
retrieved from PDB database (http://www. rcsb. org),and there is 
no experimentally resolved three dimensional structure for HLA-
A*02:03and HLA-A*02:01 in the protein data bank (PDB),structure 
was modeled by homology based modeling software MODELLER 
9.13 [23],and we used 3OX8 which is an X-ray diffraction structure 
of the HLA-A2 allele
The PRA antigen’s promiscuous epitopes were further tested by 
 with resolution of 2.16 and 1HHG an X-ray 
diffraction structure of HLA-A2 allele with resolution of 2.60 as 
templates for HLA-A*02:03,HLA-A*02:01 alleles respectively. 
 Energy minimization test was used to find out the energy 
parameters in comparison with the potential of mean force derived 
from a large set of known protein structures using Swiss PDB 
viewer. Then to evaluate backbone conformation Psi/Phi angles of 
modeled HLA allele structures Ramachandran plot obtained from 
PROCHECK [24] and checked for the presence of non-GLY residues 
in the disallowed regions.  
The modeled quality was further determined based on Z-score,an 
model quality score which used to check whether the input structure 
is within the score range that is found in native protein of similar 
size using web based tools PROVE and ERRAT which are embedded 
in the SAVES server(http://nihserver. mbi. ucla. edu/SAVES/). 
PRA antigenic peptide and HLA allele’s interaction analysis 
using docking  
in 
silico docking simulation to find out whether or not this peptide will 
bind to the HLA molecules when it will be applied in vivo. To 
accomplish peptide HLA allele interaction simulation, 
experimentally resolved and modeled HLA three dimensional 
structures of the HLA alleles HLA-A*02:03, HLA-B*27:05, HLA-
A*02:01 were docked using Autodock 4.2, a suite of automated 
docking tools designed to predict how small molecules, such as 
nanomeric peptides bind to a receptor of known 3D structure [25] 
by employing an implementation of the Lamarckian genetic 
algorithm (GA),to model the peptide binding to HLA alleles, and in 
this The input ligands and the output data were mined by python 
scripts using the MGL Tools 1.5.4 package [26]. Here all retained 
poses considered in the study had an RMSD below 2.0 Å . Further 
computational burden was minimized for calculating peptide–MHC 
interactions at positions not involved in the static docking. All 
coordinates were kept fixed apart from the peptide residues of 
interest. These were left flexible. Thus, GA settings were kept to their 
default values, apart from the number of energy evaluations and the 
number of generations which were set to 2 500 000 and 27 000, 
respectively. The docking grid was defined as a cuboid with 
respective dimensions of: 68 Å × 80 Å × 80 Å for DP1, 
72 Å × 80 Å × 82 Å for DP41, 72 Å × 80 Å × 82 Å for DP42 and 
72 Å × 80 Å × 82 Å for DP5 which encompassed the entire peptide 
binding site on DP. Output from ten independent GA runs for each 
ligand was processed and the pose (binding conformation) with the 
lowest Free Energy of Binding (FEB) was considered. FEB values 
represent the direct output from the AutoDock 4.2 scoring function 
which takes into consideration weighted terms for van der Waals 
dispersion/repulsion, hydrogen bonding, electrostatics, desolvation 
interactions, and the change in torsional free energy when the ligand 
goes from an unbound to a bound state.[25] 
RESULTS AND DISCUSSION 
The relative ability of a peptide epitope-MHC complex to elicit an 
immune response was predicted using “T cell -MHC immunogenicity 
predictors” that counts amino acid properties as well as their 
position within the peptide to predict the immunogenicity of a PRA 
antigenic epitope- HLA complex. 
The predictions of viable epitopes were done using epitope 
prediction tools. The criterion of predicting epitopes was different 
for each tool. Prediction by IEDB tool is based on IC50 value. 
MHCPred is also based on IC50 
Computationally predicted nanomeric epitopes from the pool of 182 
epitopes, only six promiscuous epitopes were modeled by PEP-FOLD 
and their energy levels were minimized using swiss pdb viewer then 
labeled using PYMOL. Then the systematic analysis proceeded to 
assess their binding efficacy for HLA alleles which are common 
among ethnic group. 
 
Table 1: Predicted promiscuous epitopes and their binding affinity calculations 
value. If value is less than 50 (>50) 
consider as binder. MAPPP is based on score value, and minimum 
score is 0.5, and for HLAPred is based on threshold value which was 
5 for the above prediction. 
Epitopes model generations 
HLA Allele Epitope IEDB IC MAPPP 50 MHCPred HLAPred 
HLA-B*27:05 ARISVSNIV 27.9 1.7 37.84 10.460 
HLA-B*27:05 GRPTASTPA 16.2 2.0 24.49 12.010 
HLA-A*02:01 ALNLFVEAL 48.9 0.66 106.91 5.600 
HLA-A*02:03 LVAAGLASA 31.3 1.49 45.29 9.090 
HLA-A*02:03 FSHALIALV 37.1 1.33 85.31 7.770 
HLA-A*02:03 AEPTHEPTE 44.7 1.0 92.04 6.460 
 
Retrieval and Modelling of HLA alleles 
Probably three-dimensional (3-D) structure of HLA alleles was 
generated by protein structure homology modeling server 
Modeller9.13. Further these modeled structures were minimized 
using Swiss PDB viewer. Then the quality of the predicted 3D 
structure of HLA-A*02:03 were confirmed by SAVE server. The 
perceived Ramchandran plot (Psi-Phi) pairs had 93.8% of residues 
in most favored regions,5.8 % core residues in additional allowed 
regions, 0.0 % residues in generously allowed regions and 0.4% 
residues in disallowed regions, finally overall quality factor of the 
model was 93.8%,where as another allele HLA-A*02:01 model 
quality was 86.54% which includes 96.2% of residues in the most 
favored region and rest of residues lies in additionally allowed and 
generously allowed region, none of the residues in the disallowed 
region. Considering these parameter the quality of the model was 
assessed as good. 
HLA and Epitopes interaction analysis using Docking studies 
It's worth noting all the parameters after docking, because it 
computes 11 types of energy values like Estimated free energy of 
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binding (EFreeBind), Final Intermolecular Energy (EInterMol), which is 
the sum of 4 energies such as vdW + Hbond + desolv Energy (EVHD), 
Electrostatic Energy (EElec), Moving Ligand-Fixed Receptor (EMLFR), 
and Moving Ligand-Moving Receptor (EMLMR) Final Total Internal 
Energy (EFTot), again the sum of 2 energy values such as Internal 
Energy Ligand (EIntL), and Internal Energy Receptor (EIntR) Torsional 
Free Energy (ETors) and unbound System's Energy (EUnb). Minimum 
energy has greater stability and vice versa. Thus Docking studies 
would reveal the insight about the favorable interactions between 
epitope and HLA alleles and based on binding energy score and 
hydrogen bonds of all docked complexes epitopes efficacy as a 
vaccine candidate was assessed. Six antigenic epitopes and their 
binding energies,total internal energy as well torsional free energy 
were listed in the Table.1. 
 
   
Fig. 1: Modeled nanomeric epitope-ARISVSNIV, GRPTASTPA, ALNLFVEA. 
 
   
Fig. 2: Modeled nanomeric epitope- LVAAGLASA, FSHALIALV, AEPTHEPTE 
 
   
Fig. 3: Modeled HLA-A*02:01 three dimensional structure and Ramachandran plot evaluation 
 
  
Fig. 4: Modeled HLA-A*02:01three dimensional structure and Ramachandran plot evaluation 
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Table 2: HLA alleles and nanomeric epitopes interaction based energy calculations 
HLA Allele Epitope E EFreeBind EFTot KTors i 
HLA-A*02:01 ALNLFVEAL -2.44 -5.88 +8.78 16.17 
HLA-A*02:01 AEPTHEPTE -2.80 -4.98 +8.51 8.85 
HLA-B*27:05 GRPTASTPA -7.69 -2.47 +7.13 20.39 
HLA-B*27:05 ARISVSNIV -5.27 -1.18 +9.33 28.31 
HLA-A*02:03 LVAAGLASA -4.72 -3.89 +6.86 345.79 





Fig. 5: Binding pose of ARISVSNIV nanomeric peptide on HLA-B*27:05 
 
                    
Fig. 6: Binding pose of ALNLFVEAL nanomeric peptide on HLA-A*02:01 
 
                  
Fig. 7: Binding pose of LVAAGLASA nanomeric peptide on HLA-A*02:03 
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Fig. 8: Binding pose of FSHALIALV nanomeric peptide on HLA-A*02:03 
 
  
Fig. 9: Binding pose of AEPTHEPTE nanomeric peptide on HLA-A*02:01 
 
                            
Fig. 10: Binding pose GRPTASTPA of nanomeric peptide on HLA-B*27:05 
 
Table 3: Interacting residues of HLA alleles with nanomeric peptides 
Allele Epitope H-Bonds 










HLA-A*02:01 ALNLFVEAL ARG30- LEU4 
ARG30- ALA8 
THR257- ALA1 




HLA-A*02:03 FSHALIALV PHE1- ASP54 
PHE1- ASP53 
TYR51- SER2 
HLA-A*02:01 AEPTHEPTE TYR51- GLU2 
ILE237- GLU9 
Christy et al. 
Int J Pharm Pharm Sci, Vol 6, Issue 9, 238-343 
243 
Here we attempt to explore the use of intermolecular bonding 
patterns of HLA alleles and it is clear that peptide/HLA structural 
interaction patterns vary among different alleles and may be based 
on family dependent manner. The results obtained here would 
provide an insight of peptide binding motifs or receptor information. 
From the molecular docking energy table, we observed that epitope 
GRPTASTPA have the minimum binding energy i.e. -7.69 Kcal/Mol 
among all other epitopes and AEPTHEPTE epitope has the maximum 
energy i. e. -2.80 Kcal/Mol. From the docking interaction table, it is 
clear that we have 6 epitopes, out of which five nanomeric epitopes 
have more hydrogen bonding with considerable bond distance 
(ARISVSNIV, ALNLFVEAL, LVAAGLASA, FSHALJALV, AEPTHEPTE,) 
with the HLA alleles. 
CONCLUSION  
Vaccine development for coccidiomycosis is based on screening of 
multiple antigenic epitopes that direct the immune system to protect 
the host from fungal infection. The purpose of the present study was 
screening the new immunogenic HLA class I restricted cytotoxic T 
cell (CTL) epitopes of PRA antigen and analyzing their interaction 
with HLA alleles. Promiscuous epitopes like ARISVSNIV,ALNLFVEAL, 
LVAAGLASA, FSHALJALV, AEPTHEPTE interacting with HLA class I 
alleles like HLA-B*27:05, HLA-A*02:03, HLA-A*02:01 and exhibiting 
minimal binding energy for MHC-I receptor. So these epitopes are 
the good binders for MHC-I which can be the key factor for 
developing the diagnostic tool as well as a vaccine candidate for 
coccidiomycosis. Epitopes binding sites analysis would be beneficial 
for protein function annotation and designing the structure based 
drugs. 
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